The Hughes Report

States once rolled out the red carpet for data centers. Now, as the AI boom strains power grids and budgets, a wave of legislative scrutiny is brewing.

A $15.2M deal in Lehigh Valley reveals a new playbook for private equity: returning capital to investors without exiting a high-performing asset.

Novartis unveils groundbreaking Phase III data for Rhapsido, offering hope as the first potential targeted therapy for 29 million chronic hive sufferers.

As Ontario doctors adopt AI to fight burnout, a new training program from OntarioMD tackles the urgent medico-legal and privacy risks head-on.

Desgagnés launches the M/V Johane A. Desgagnés, part of a $140M fleet expansion aimed at dominating Arctic shipping and honoring a key family member.

Clare Cunningham's promotion at conceptcsi isn't just a new title; it's a strategic move signaling a new era of data-driven leadership in construction.

With $850M in new capital, Base10 Partners doubles down on its 'Real Economy AI' thesis, proving that automating traditional industries is venture's next frontier.

Ricoh partners with startup Thread AI to automate facilities using digital twins and AI orchestration, signaling a shift from AI experiments to scalable operations.

A new report projects a $2.4T western wear market, but the real story is the strategic upheaval. AI, sustainability, and global shifts are the new threads.

InstallatørGruppen's strong Nasdaq debut was a win for the green transition, but a price dip and a quick correction reveal the complex realities of going public.

With its pivotal Phase 3 trial complete, Rafael Holdings is on a path to redefine treatment for NPC and transform itself into a commercial-stage biotech.

As AI upends search, Optimizely's new platform uses log data and Conductor's intelligence to show marketers what AI agents are doing and why.

Carestream's new Lux HD detectors blend high-res imaging, AI, and rugged design to boost diagnostics, streamline workflows, and challenge market rivals.

A new AI tool from Feedzai gives regional and mid-sized banks access to network intelligence once reserved for giants, promising a major leap in fraud detection.

With a novel 'gastric bypass in a pill' and a new CFO known for orchestrating lucrative exits, Syntis Bio is gearing up for a high-stakes battle in the booming obesity drug market.

MEXC launches multi-event 'Combo' trading, claiming a global first. But with established rivals, high risks, and a maze of regulations, is it innovation?

U.S. firm Arcova lands a key Saudi contract, a strategic move tying its practitioner-led expertise to the Kingdom's multi-trillion-dollar digital future.

New data on elecoglipron, an oral pill with no food restrictions, shows major weight loss and A1C reduction, positioning AstraZeneca to disrupt the GLP-1 market.

BeyondTrust joins Anthropic's Project Glasswing, wielding the frontier AI Claude Mythos to defend critical infrastructure and tackle the new threat of AI agents.

A new report reveals a stark disconnect: formal AI investments show no return, while a vast, ungoverned 'shadow AI' economy driven by employees delivers real gains.